CAPED (Cancer Awareness, Prevention & Early Detection Trust), with the support of AstraZeneca India and OneStage (formerly Charities Aid Foundation India), continues to make a significant impact in women’s healthcare through its Ganga Godavari Cancer Screening Program. Now in its third year, the initiative has successfully screened over 18,600 women for cervical, breast, and oral cancer, focusing on awareness and screening for early detection among underprivileged communities.

Building on the success of its first year in Mathura (2022-23), where 4,605 women were screened, the project expanded to Delhi in 2023-24, screening 6,037 women across 55 camps. This year, the program set an ambitious target of screening 8,000 women by March 2025, with 6,893 women already screened across 70 screening camps as of March 8, 2025.